Ractigen Therapeutics, a clinical-stage Pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in the Phase I ...
A recently published, comprehensive systematic review and meta-analysis has added to the growing body of evidence showing that beef can be enjoyed in a heart-healthy diet.
The ISCHEMIA Trial randomly assigned patients with ischemic heart disease to an invasive treatment strategy centered on revascularization with a control group assigned non-invasive medical therapy. As ...
Randomized Phase 2 study initiated evaluating the combination of casdozokitug ... ("Coherus,” NASDAQ: CHRS) today announced that an abstract highlighting final clinical and biomarker data from its ...